Nanoscope Therapeutics Inc.
Michael Marquez is currently the CFO at Nanoscope Therapeutics Inc. Prior to this role, Michael held the CFO position at TearLab Corporation from September 2015 to June 2022 and at Alcon from May 2008 to September 2015. Michael has a BBA in Accounting from The University of Texas at Austin and a Master's degree in Accounting from The University of Texas at Arlington. Michael also has experience working as an Associate at PwC from June 2005 to May 2008. Additionally, Michael has participated in executive education programs at the University of Chicago Booth School of Business and Kellogg Executive Education.